Superb Dx and AIxMed team up to bring AI-driven urine cytology to Superb Dx’s reference lab capabilities, targeting ...

The findings of a new study add to growing evidence that cotesting may offer limited clinical value despite its common use in ...

Under the MOU, Biopticka will be designated as a reference site for AIxMed in Europe, demonstrating the real-world application of AIxURO™ to prospective partners and clients. Supported by AIxMed's ...

Through a Combination of Advanced Imaging and Novel Artificial Intelligence, Latest Diagnostic System for Cervical Cancer Screening Can Help More Accurately Detect Disease, Improve Workflow and ...

Previous studies have indicated that human papillomavirus (HPV) testing as a triage for managing equivocal cytology is cost-effective. The aim of this study was to assess the costs of alternative roll ...

SANTA CLARA, Calif., Oct. 2, 2025 /PRNewswire/ -- AIxMed Inc., a leader in computational cytology and AI-powered diagnostics, and Biopticka Laboratoř s.r.o., the Czech Republic's leading private ...